All Stories

  1. Cost-effectiveness of erenumab for the prevention of episodic and chronic migraine

    Article • Cephalalgia, August 2018, SAGE Publications

    Matthew Sussman

  2. Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy

    Article • ClinicoEconomics and Outcomes Research, June 2014, Taylor & Francis

    Matthew Sussman